The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia

John D. McConnell, Claus G. Roehrborn, Oliver Bautista, Gerald L. Andriole, Christopher Dixon, John W. Kusek, Herbert Lepor, Kevin T. McVary, Leroy M. Nyberg, Harry S. Clarke, E. David Crawford, Ananias C. Diokno, John P. Foley, Harris E. Foster, Stephen C. Jacobs, Steven A. Kaplan, Karl J. Kreder, Michael M. Lieber, M. Scott Lucia, Gary J. Miller, Mani Menon, Douglas F. Milam, Joe Ramsdell, Noah S. Schenkman, Kevin M. Slawin, Joseph A. Smith

New England Journal of Medicine, 2003

The University of Texas Southwestern Medical Center, New York University, National Institute of Diabetes and Digestive and Kidney Diseases, Northwestern University, Emory University, University of Colorado Health, Beaumont Hospital, Royal Oak, Joint Base San Antonio, San Antonio Military Medical Center, Yale University, University of Maryland, Baltimore, NewYork–Presbyterian Hospital, University of Iowa, Mayo Clinic in Arizona, Henry Ford Hospital, Vanderbilt University, University of California, San Diego, Walter Reed Army Institute of Research, Baylor College of Medicine

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with New England Journal of Medicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

2028

Citations

View on Google Scholar

The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia

Abstract

Journal Details

Join JournalsHub

Welcome Back